Heidy King-Jones is Chief Legal Officer of Provention Bio Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Spyre Therapeutics, Inc.
2 Feb 24
4
Aeglea BioTherapeutics, Inc.
5 Sep 23
3
Aeglea BioTherapeutics, Inc.
5 Sep 23
4
Provention Bio, Inc.
27 Apr 23
4
Provention Bio, Inc.
11 Jan 23
4
Provention Bio, Inc.
23 Nov 22
4
Provention Bio, Inc.
24 Mar 22
4
Provention Bio, Inc.
20 Jan 22
4
Provention Bio, Inc.
5 Aug 21
4
Provention Bio, Inc.
14 May 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Feb 24 | SYRE Spyre Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 25.86 | 63,000 | 1.63 mm | 63,000 |
1 Sep 23 | SYRE Spyre Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.58 | 13,495,255 | 7.83 mm | 13,495,255 |
27 Apr 23 | PRVB Provention Bio | Option to Purchase Common Stock Common Stock | Sale back to company | Dispose D | No | No | 8.93 | 200,000 | 1.79 mm | 0 |
27 Apr 23 | PRVB Provention Bio | Option to Purchase Common Stock Common Stock | Sale back to company | Dispose D | No | No | 4.39 | 145,000 | 636.55 k | 0 |
27 Apr 23 | PRVB Provention Bio | Option to Purchase Common Stock Common Stock | Sale back to company | Dispose D | No | No | 6.8 | 139,500 | 948.60 k | 0 |
27 Apr 23 | PRVB Provention Bio | Option to Purchase Common Stock Common Stock | Sale back to company | Dispose D | No | No | 11.23 | 300,000 | 3.37 mm | 0 |
10 Jan 23 | PRVB Provention Bio | Stock Option Common Stock, par value $0.0001 | Grant | Acquire A | No | No | 8.93 | 200,000 | 1.79 mm | 200,000 |